Ahlberg J, Blomstrand C, Ronquist G, Wikkelsö C
Acta Neurol Scand. 1985 Nov;72(5):525-7. doi: 10.1111/j.1600-0404.1985.tb00912.x.
Adenylate kinase (AK) was determined in a lumbo-cisternal cerebrospinal fluid (CSF) gradient and in CSF from patients with mental deterioration. AK activity was unchanged in the gradient and different from albumin and albumin ratio (alb CSF/albumin serum), a blood-brain barrier marker in the same gradient. No differences between normal pressure hydrocephalus, multiinfarct dementia and dementia of the Alzheimer type could be found with regard to adenylate kinase activity in CSF.
测定了腰大池-脑池脑脊液（CSF）梯度以及精神衰退患者脑脊液中的腺苷酸激酶（AK）。在该梯度中，AK活性未发生变化，且与同一梯度中的血脑屏障标志物白蛋白及白蛋白比率（脑脊液白蛋白/血清白蛋白）不同。在脑脊液腺苷酸激酶活性方面，正常压力脑积水、多发梗死性痴呆和阿尔茨海默型痴呆之间未发现差异。
